APPA, an aldose reductase inhibitor, demonstrates efficacy in preventing apoptosis and symptoms of Streptozotocin-induced diabetes in rats through inhibition of the polyol pathway. This compound shows promise for research into diabetic nephropathy (DN) [1].
Molecular Weight:
243.26
CAS Number:
[100750-39-8]
Formula:
C14H13NO3
Target:
Apoptosis|||Reductase
T78612
* VAT and and shipping costs not included. Errors and price changes excepted
